Serena Williams built a life around discipline. She is not the celebrity version of “I tried everything.” She is a 23-time Grand Slam champion, one of the most intensely trained athletes of the modern era, and someone whose body has been analyzed in public since she was a teenager.

So when Williams opened up about using a GLP-1 medication after struggling with post-pregnancy weight changes, the story landed differently. It was not about laziness. It was not about a shortcut. It was about biology, motherhood, and the relief of finally finding something that worked.

In August 2025, Williams publicly shared that she was using Zepbound (tirzepatide) through the telehealth company Ro. Her story is worth your attention for the same reason Shaq’s Zepbound story was: not the celebrity, but what it reveals about how even the most disciplined people hit walls that effort alone can’t break through.

Why Serena’s story matters

Williams said that after having children — especially after the birth of her second daughter in 2023 — she felt like her body would not respond the way it once had. She described training, eating well, running, doing high-intensity workouts, dancing, and still hitting a wall she could not break through.

For someone whose entire identity was built on out-working everyone, that admission is the whole story in miniature. If one of the most disciplined athletes in history can struggle after childbirth, the conversation about weight has to mature past willpower. Hormones, appetite signaling, pregnancy, sleep, stress, and metabolic health all matter.

Vogue reported that Williams partnered with Ro to discuss her experience — and noted an important conflict-of-interest detail: her husband, Alexis Ohanian, is an investor in Ro and serves on its board.

One thing to be clear-eyed about: this is a branded campaign, not just a personal health story. Williams is a paid partner of Ro, and her family has a financial stake in the company. That doesn’t make her experience false — but you should read every celebrity health story with the sponsorship in plain view. We flagged the same thing in Shaq’s Lilly campaign, and the rule doesn’t change because the athlete does.

The numbers — and why they’re not the point

The headline figures are dramatic. In her initial announcement, Williams said she had lost about 31 pounds; roughly a year into treatment, she put the figure at 34 pounds and told reporters the medication had made her feel healthier than at any point in her life — including improvements in markers like cholesterol and blood sugar. She described getting back into tennis, walking, running, and Pilates.

But read her comments closely and the more interesting change is psychological. Williams told Vogue she felt more like her old self — more confident, lighter mentally. For some patients, the biggest shift isn’t the scale. It’s the relief of no longer feeling like their body is fighting them every day.

What Serena actually took

The medication Williams discussed is Zepbound, whose active ingredient is tirzepatide — the same synthetic peptide medication in Shaq’s story. It’s based on the GIP hormone sequence and acts as a dual agonist on two of your gut’s natural hormone signals:

  • GLP-1 (glucagon-like peptide-1) — signals fullness to your brain, slows stomach emptying, and helps regulate insulin.
  • GIP (glucose-dependent insulinotropic polypeptide) — a second incretin hormone that works alongside GLP-1 on appetite and how your body handles glucose and fat.

The FDA approved Zepbound in November 2023 for chronic weight management in adults with obesity, or overweight with at least one weight-related condition — explicitly alongside a reduced-calorie diet and increased physical activity.

If GLP-1 drugs are new territory for you, our explainer on what GLP-1 peptides are and what the research shows covers the trial data in more depth.

The postpartum angle nobody should skip

Serena’s story resonates because many women know the frustration of doing “everything right” and still feeling stuck. Pregnancy, postpartum recovery, hormonal shifts, and aging can genuinely change how the body responds to food and exercise. That doesn’t mean lifestyle stops mattering. It means lifestyle isn’t always the whole story.

Williams has been clear that the medication did not replace effort — she continued training and eating well while using the GLP-1. That’s the most responsible takeaway: medication can be a tool inside a lifestyle, not a replacement for one. Zepbound’s own label requires it.

For the longevity-minded reader, the deeper pattern is the same one we keep returning to: the old model was “push harder.” The newer model is “understand the system.” If appetite regulation, insulin, inflammation, sleep, or hormones are working against you, more discipline may not solve the root issue — the same logic behind boring fundamentals like zone 2 cardio for mitochondrial health.

This is not the same as buying peptides online

Serena’s tirzepatide came through a licensed telehealth provider, a prescription, and the regulated pharmaceutical supply chain. The vials of “tirzepatide” sold by online peptide vendors are a different universe.

The FDA has publicly warned about unapproved GLP-1 products: unapproved versions never go through FDA review for safety, effectiveness, or quality, and some illegally marketed products have been found to contain the wrong ingredient, too little or too much active ingredient, or no active ingredient at all.

A peptide labeled “for research use only” is not a budget version of Zepbound. It is an unverified chemical with no guarantee of identity, purity, sterility, or concentration. One useful tell: reputable, science-led wellness brands like Soma Bloom don’t sell GLP-1 compounds at all. Any brand offering “research tirzepatide” or GLP-1 vials directly to the public is selling exactly the category of product the FDA is warning about.

Safety, supervision, and what we’re not saying

  • We are not suggesting you should take Zepbound or any GLP-1. That’s a decision for you and a licensed clinician who knows your history — especially postpartum, where breastfeeding and hormonal recovery add real considerations.
  • These medications have real side effects. The FDA lists nausea, diarrhea, vomiting, constipation, fatigue, and injection-site reactions as common, plus serious warnings involving pancreatitis, gallbladder problems, kidney injury, low blood sugar in certain combinations, and suicidal behavior or thinking.
  • No drug is a “cure.” Stopping GLP-1 medications typically leads to weight regain without sustained lifestyle change.
  • If postpartum weight feels immovable despite real effort, the move isn’t a vial from the internet. It’s labs, a conversation with a doctor, and an honest look at sleep, hormones, and metabolic markers. Diagnosis first. Always.

Key lessons for biohackers

  1. Discipline is not invincibility. Serena Williams out-trained everyone on earth for two decades and still needed medical help postpartum. “I should be able to force this” is not a health strategy.
  2. Biology changes; plans should too. Pregnancy, hormones, and age shift the system you’re optimizing. Re-test instead of re-blaming yourself.
  3. The shift from shame to data is the real biohack. Not the injection, not the campaign — the willingness to ask “what is my biology actually doing?” and act on the answer.
  4. Regulated beats gray-market. The molecule isn’t the only thing that matters. The supply chain is part of the safety profile.
  5. Read the sponsorship. Serena’s story is real and it’s part of a campaign her family profits from. Holding both facts at once is exactly the media literacy this space requires.

The bottom line

Serena Williams’ GLP-1 story is powerful because it reframes strength. Strength is not pretending your body has no limits. Strength is paying attention, getting tested, getting help through proper channels, and being honest about what’s working.

The lesson is not that peptides are magic. Real transformation usually comes from a stack: medical guidance, lifestyle, consistency, and the humility to change the plan when the old one stops working.

Readers who want a science-led wellness angle on peptides and longevity can browse Soma Bloom’s shop — an education-first catalog of wellness rituals built around vitality, longevity, hormonal balance, and rest.

To be clear and consistent with everything above: Soma Bloom does not sell tirzepatide, semaglutide, or any GLP-1 compound — and you should be skeptical of any brand that markets GLP-1 drugs directly to the public. Soma Bloom’s products are wellness formulations, not prescription medications, and are not intended to diagnose, treat, cure, or prevent any disease. For clinical access to FDA-approved GLP-1 medications, talk to your physician or a licensed telehealth provider.

This article is for educational purposes only and is not medical advice. It does not endorse or recommend any medication. Zepbound is a prescription medicine with significant potential side effects; talk to a licensed healthcare professional about any concerns regarding weight, postpartum health, or whether any treatment is appropriate for you. Serena Williams’ partnership with Ro is a paid commercial relationship, and her husband holds a financial stake in the company. Biohack Library has a commercial relationship with Soma Bloom and may earn revenue from purchases made through the links above. Soma Bloom is a wellness brand and does not sell GLP-1 medications.

Sources